A. O'Dowd

574 total citations
21 papers, 423 citations indexed

About

A. O'Dowd is a scholar working on Physiology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, A. O'Dowd has authored 21 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Organic Chemistry and 4 papers in Pathology and Forensic Medicine. Recurrent topics in A. O'Dowd's work include Free Radicals and Antioxidants (4 papers), Biochemical effects in animals (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). A. O'Dowd is often cited by papers focused on Free Radicals and Antioxidants (4 papers), Biochemical effects in animals (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). A. O'Dowd collaborates with scholars based in United Kingdom, Czechia and Japan. A. O'Dowd's co-authors include J. J. F. Belch, David Ansell, Rajan Madhok, R D Sturrock, D.J. Miller, R D Sturrock, Chak Sing Lau, C. G. Gemmell, C.D. Forbes and John J. O'Dowd and has published in prestigious journals such as The Journal of Physiology, Annals of the New York Academy of Sciences and BMJ.

In The Last Decade

A. O'Dowd

20 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. O'Dowd United Kingdom 11 106 84 82 79 73 21 423
Juan José Moreno Spain 9 92 0.9× 133 1.6× 63 0.8× 28 0.4× 30 0.4× 15 584
Edimar Cristiano Pereira Brazil 11 47 0.4× 80 1.0× 69 0.8× 28 0.4× 20 0.3× 43 388
Katsushi Takahashi Japan 9 56 0.5× 32 0.4× 43 0.5× 127 1.6× 40 0.5× 14 358
Motonori Fukumura Japan 15 34 0.3× 170 2.0× 95 1.2× 31 0.4× 14 0.2× 43 604
F.Z.G.A. Cyrino Brazil 16 22 0.2× 109 1.3× 162 2.0× 33 0.4× 12 0.2× 43 596
Nihayet Bayraktar Türkiye 11 57 0.5× 46 0.5× 35 0.4× 47 0.6× 13 0.2× 31 429
Karim Mowla Iran 11 112 1.1× 31 0.4× 34 0.4× 33 0.4× 139 1.9× 31 452
C. Murray Ardies United States 15 27 0.3× 110 1.3× 26 0.3× 93 1.2× 17 0.2× 21 513
Manal Fardoun Lebanon 13 23 0.2× 65 0.8× 31 0.4× 55 0.7× 15 0.2× 23 522
H. Bukowska Poland 10 114 1.1× 144 1.7× 55 0.7× 29 0.4× 54 0.7× 25 513

Countries citing papers authored by A. O'Dowd

Since Specialization
Citations

This map shows the geographic impact of A. O'Dowd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. O'Dowd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. O'Dowd more than expected).

Fields of papers citing papers by A. O'Dowd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. O'Dowd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. O'Dowd. The network helps show where A. O'Dowd may publish in the future.

Co-authorship network of co-authors of A. O'Dowd

This figure shows the co-authorship network connecting the top 25 collaborators of A. O'Dowd. A scholar is included among the top collaborators of A. O'Dowd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. O'Dowd. A. O'Dowd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O'Dowd, A.. (2014). NHS plans new workforce for long term conditions. BMJ. 349(sep16 17). g5667–g5667. 1 indexed citations
2.
O'Dowd, A.. (2013). NHS is on track to meet 65% of efficiency target by April, officials say. BMJ. 346(jan16 3). f346–f346. 2 indexed citations
4.
O'Dowd, A.. (2011). Some PCTs recommend GPs limit prescriptions to 28 days. BMJ. 342(apr13 3). d2410–d2410. 4 indexed citations
5.
O'Dowd, A.. (2010). NHS pay rise may be capped below 1% for next few years. BMJ. 340(jan22 3). c459–c459. 1 indexed citations
6.
O'Dowd, A.. (2009). Reducing greenhouse emissions could cut global disease burden by 25%. BMJ. 338(mar16 2). b1092–b1092. 1 indexed citations
7.
Miller, D.J. & A. O'Dowd. (2000). Vascular smooth muscle actions of carnosine as its zinc complex are mediated by histamine H(1) and H(2) receptors.. PubMed. 65(7). 798–806. 16 indexed citations
8.
O'Dowd, A. & D.J. Miller. (1998). Analysis of an H1 receptor‐mediated, zinc‐potentiated vasoconstrictor action of the histidyl dipeptide carnosine in rabbit saphenous vein. British Journal of Pharmacology. 125(6). 1272–1280. 12 indexed citations
9.
O'Dowd, A., John J. O'Dowd, & D.J. Miller. (1996). The dipeptide carnosine constricts rabbit saphenous vein as a zinc complex apparently via a serotonergic receptor.. The Journal of Physiology. 495(2). 535–543. 11 indexed citations
10.
McGrath, J.C., Christine M. Brown, C.J. Daly, et al.. (1995). The Relationship between the Adrenoceptor and Nonadrenoceptor‐Mediated Effects of Imidazoline‐ and Imidazole‐Containing Compoundsfn1. Annals of the New York Academy of Sciences. 763(1). 591–605. 6 indexed citations
11.
Veale, Douglas J., et al.. (1994). A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF EFAMOL MARINE ON SKIN AND JOINT SYMPTOMS OF PSORIATIC ARTHRITIS. Lara D. Veeken. 33(10). 954–958. 48 indexed citations
12.
O'Dowd, A., John J. O'Dowd, Niall G. MacFarlane, Hiroki Abe, & D.J. Miller. (1992). Analysis of novel imidazoles from isolated perfused rabbit heart by two high-performance liquid chromatographic methods. Journal of Chromatography B Biomedical Sciences and Applications. 577(2). 347–353. 12 indexed citations
13.
Lau, Chak Sing, A. O'Dowd, & J. J. F. Belch. (1992). White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome.. Annals of the Rheumatic Diseases. 51(2). 249–252. 49 indexed citations
14.
Belch, J. J. F., A. O'Dowd, David Ansell, & R D Sturrock. (1989). Leukotriene B4Production by Peripheral Blood Neutrophils in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 18(4). 213–219. 10 indexed citations
15.
Belch, J. J. F., M. McLaren, M. Chopra, A. O'Dowd, & C.D. Forbes. (1989). Coagulation and haemorheological abnormalities in patients with vibration white finger. Discovery Research Portal (University of Dundee). 18–28. 2 indexed citations
16.
Belch, J. J. F., David Ansell, Rajan Madhok, A. O'Dowd, & R D Sturrock. (1988). Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study.. Annals of the Rheumatic Diseases. 47(2). 96–104. 156 indexed citations
17.
Belch, J. J. F., John Drury, Kevin McLaughlin, et al.. (1987). Abnormal Biochemical and Cellular Parameters in the Blood of Patients with Raynauds Phenomenon. Scottish Medical Journal. 32(1). 12–14. 15 indexed citations
18.
Belch, J. J. F., et al.. (1986). Evening primrose oil (efamol) as a treatment for cold-induced vasospasm (Raynauds Phenomenon). Progress in Lipid Research. 25. 335–340. 3 indexed citations
19.
Belch, J. J. F., Brandon S. Shaw, A. O'Dowd, et al.. (1985). Evening Primrose Oil (Efamol) in the Treatment of Raynaud’s Phenomenon: A Double Blind Study. Thrombosis and Haemostasis. 54(2). 490–494. 30 indexed citations
20.
Gemmell, C. G. & A. O'Dowd. (1983). Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes. Journal of Antimicrobial Chemotherapy. 12(6). 587–597. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026